Frank Lichtenberg : Citation Profile

National Bureau of Economic Research (NBER) (30% share)
CESifo (10% share)
Columbia University (60% share)

27

H index

47

i10 index

3466

Citations

RESEARCH PRODUCTION:

87

Articles

89

Papers

13

Chapters

RESEARCH ACTIVITY:

   43 years (1981 - 2024). See details.
   Cites by year: 80
   Journals where Frank Lichtenberg has often published
   Relations with other researchers
   Recent citing documents: 75.    Total self citations: 82 (2.31 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pli76
   Updated: 2025-12-20    RAS profile: 2024-09-28    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Blankart, Katharina (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Frank Lichtenberg.

Is cited by:

Hall, Bronwyn (31)

van Reenen, John (31)

Madsen, Jakob (21)

Siegel, Donald (19)

Quatraro, Francesco (19)

Keller, Wolfgang (18)

Wiederhold, Simon (18)

MAIRESSE, Jacques (17)

Ang, James (16)

Kyle, Margaret (16)

Vivarelli, Marco (16)

Cites to:

Lleras-Muney, Adriana (18)

Sakellaris, Plutarchos (13)

Wilson, Daniel (13)

Romer, Paul (12)

Siegel, Donald (12)

Nordhaus, William (12)

Helpman, Elhanan (12)

topel, robert (9)

DUFLOS, Gautier (9)

Murphy, Kevin (9)

Linn, Joshua (9)

Main data

Where Frank Lichtenberg has published?

Journals with more than one article published# docs
Forum for Health Economics & Policy7
The Review of Economics and Statistics5
Economics of Innovation and New Technology5
International Journal of Health Economics and Management4
American Economic Review4
Economics & Human Biology3
Journal of Industrial Economics3
Social Science & Medicine3
Journal of Economic Behavior & Organization3
Journal of Law and Economics2
Research Policy2
International Journal of the Economics of Business2
Health Economics2
Managerial and Decision Economics2
Annals of Economics and Statistics2
PharmacoEconomics2

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc57
CESifo Working Paper Series / CESifo9
Working Papers / Center for Economic Studies, U.S. Census Bureau3
SOI - Working Papers / Socioeconomic Institute - University of Zurich2
ULB Institutional Repository / ULB -- Universite Libre de Bruxelles2

Recent works citing Frank Lichtenberg (2025 and 2024)

YearTitle of citing document
2024Should I stay or should I go? Effects of being acquired on employee outcomes: evidence from Brazil.. (2024). Liwski, Joaquín ; Matas, Liwski Joaqun. In: Asociación Argentina de Economía Política: Working Papers. RePEc:aep:anales:4740.

Full description at Econpapers || Download paper

2024Private equity financing & firm productivity. (2024). Wilson, Nicholas ; Tsoukalas, John ; Lavery, Paul. In: Working Papers. RePEc:anj:wpaper:041.

Full description at Econpapers || Download paper

2025Recovering latent linkage structures and spillover effects with structural breaks in panel data models. (2025). Okui, Ryo ; Wang, Wendun ; Sun, Yutao. In: Papers. RePEc:arx:papers:2501.09517.

Full description at Econpapers || Download paper

2024How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies. (2024). Liebman, Eli ; Fernando, Lasanthi ; Dunn, Abe C. In: BEA Papers. RePEc:bea:papers:0132.

Full description at Econpapers || Download paper

2025Les rachats à effet de levier : montages financiers risqués ou opportunités de développement pour les entreprises ?. (2025). Collet, Lucille. In: Bulletin de la Banque de France. RePEc:bfr:bullbf:2025:260:04.

Full description at Econpapers || Download paper

2024Caveat emptor as an obstacle to business transfers: Effect of product line liability exceptions on acquisitions, entry, and exit. (2024). Xu, Wenjian ; Sivadasan, Jagadeesh ; Balasubramanian, Natarajan. In: Strategic Management Journal. RePEc:bla:stratm:v:45:y:2024:i:7:p:1300-1325.

Full description at Econpapers || Download paper

2025The Innovation Dividend of Defense R&D. (2025). van Reenen, John ; Steinwender, Claudia ; moretti, enrico. In: EconPol Forum. RePEc:ces:epofor:v:26:y:2025:i:03:p:46-51.

Full description at Econpapers || Download paper

2024To leave or to stay: Digital economy development and migrant workers’ location. (2024). Wei, Xiahai ; Lou, Shiyan ; Yu, Lingzheng ; Wang, Jiannan. In: Journal of Asian Economics. RePEc:eee:asieco:v:94:y:2024:i:c:s1049007824000873.

Full description at Econpapers || Download paper

2025Green public procurement, external pressures and enterprise green transition: Evidence from China. (2025). Gao, Jinqi ; Lu, Fan. In: Journal of Asian Economics. RePEc:eee:asieco:v:98:y:2025:i:c:s1049007825000600.

Full description at Econpapers || Download paper

2024Foreign investors, firm level productivity, and European economic integration. (2024). Phylaktis, Kate ; Bailey, Warren ; Muradoglu, Gulnur ; Onay, Ceylan. In: Journal of Corporate Finance. RePEc:eee:corfin:v:85:y:2024:i:c:s0929119924000269.

Full description at Econpapers || Download paper

2025Investment and endogenous efficiency in a contest. (2025). Nilssen, Tore ; Kundu, Tapas ; Clark, Derek J. In: Economics Letters. RePEc:eee:ecolet:v:247:y:2025:i:c:s0165176524006153.

Full description at Econpapers || Download paper

2025Intermediate import diversification, knowledge source diversity and firm innovation: Micro-level evidence from Chinese listed companies. (2025). Liu, Shangbin ; Yun, Wei ; Cao, Jie. In: Economics Letters. RePEc:eee:ecolet:v:247:y:2025:i:c:s0165176524006220.

Full description at Econpapers || Download paper

2025Know thy enemy: Information acquisition in contests. (2025). Chen, Zhuoqiong. In: European Economic Review. RePEc:eee:eecrev:v:177:y:2025:i:c:s0014292125001011.

Full description at Econpapers || Download paper

2024The changing relationship between bodyweight and longevity in high- and low-income countries. (2024). Kopinska, Joanna ; Atella, Vincenzo ; Bhattacharya, Jay ; Miller, Grant. In: Economics & Human Biology. RePEc:eee:ehbiol:v:54:y:2024:i:c:s1570677x24000443.

Full description at Econpapers || Download paper

2025The impact of FDI- and import-related technology spillovers from government-funded green energy R&D in developed countries on CO2 emissions in developing countries. (2025). Herzer, Dierk. In: Energy Policy. RePEc:eee:enepol:v:203:y:2025:i:c:s0301421525001429.

Full description at Econpapers || Download paper

2024Reasons for M&A: A perspective from senior executives rural experiences- Evidence from Chinese private listed companies. (2024). Xiao, Xiaohong ; He, Xiaogang ; Peng, Jinxia. In: International Review of Financial Analysis. RePEc:eee:finana:v:93:y:2024:i:c:s1057521924001418.

Full description at Econpapers || Download paper

2024Political risk of green public procurement and firms green innovation. (2024). Song, Zilong ; Huang, Xiang ; Wang, Jiaxin ; Sun, DI ; Liu, Chengxin. In: Finance Research Letters. RePEc:eee:finlet:v:62:y:2024:i:pb:s1544612324002654.

Full description at Econpapers || Download paper

2024When banks become pure creditors: The effects of declining shareholding by Japanese banks on bank lending and firms’ risk-taking. (2024). Uesugi, Iichiro ; Ono, Arito ; Suzuki, Katsushi. In: Journal of Financial Stability. RePEc:eee:finsta:v:73:y:2024:i:c:s1572308924000792.

Full description at Econpapers || Download paper

2024The behavioral additionality of government research grants. (2024). Widmann, Rainer. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:93:y:2024:i:c:s0167718723001145.

Full description at Econpapers || Download paper

2024What a difference an OFDI makes. Firm-level evidence from the EU. (2024). Gattai, Valeria ; Akta, Koray ; Natale, Piergiovanna. In: International Economics. RePEc:eee:inteco:v:180:y:2024:i:c:s211070172400060x.

Full description at Econpapers || Download paper

2025The role of airports in enhancing total factor productivity: Evidence from listed companies in China. (2025). Song, GE ; Tan, Jing ; Yao, Zhenjiu. In: Journal of Air Transport Management. RePEc:eee:jaitra:v:124:y:2025:i:c:s0969699724002035.

Full description at Econpapers || Download paper

2024The nonlinear relationship between employee stock ownership plans and firm performance: Evidence from China. (2024). Dasilas, Apostolos. In: Journal of Business Research. RePEc:eee:jbrese:v:173:y:2024:i:c:s0148296323008299.

Full description at Econpapers || Download paper

2024The more, the better: The influence of overconfident CEOs on their firms’ digital orientation. (2024). Strese, Steffen ; Saesen, Julie ; Hedwig, Corinna Vera. In: Journal of Business Research. RePEc:eee:jbrese:v:183:y:2024:i:c:s0148296324003138.

Full description at Econpapers || Download paper

2025CEO–TMT vertical pay gap and firm productivity: A tournament theory perspective. (2025). Wang, Chen ; Ponnapalli, Ajay Rama ; Xu, LE. In: Journal of Business Research. RePEc:eee:jbrese:v:197:y:2025:i:c:s0148296325002760.

Full description at Econpapers || Download paper

2024Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D. (2024). Hermosilla, Manuel. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629623001327.

Full description at Econpapers || Download paper

2024Growth gains from offshore outsourcing. (2024). Marjit, Sugata ; Veeramani, C ; Basu, Anwesha. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:46:y:2024:i:1:p:90-112.

Full description at Econpapers || Download paper

2025Is there worldwide convergence toward the SDGs?. (2025). Micheli, Silvia ; Bigerna, Simona. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:47:y:2025:i:1:p:97-117.

Full description at Econpapers || Download paper

2024The impact of government procurement on green technological innovation: Evidence from manufacturing sector in china. (2024). Qiu, Yumin ; Liu, Xiaofeng ; Zhou, Wenxiang ; Miao, Haoran. In: Pacific-Basin Finance Journal. RePEc:eee:pacfin:v:86:y:2024:i:c:s0927538x24002087.

Full description at Econpapers || Download paper

2024Executive pay restrictions, political promotion, and firm efficiency: Evidence from China. (2024). Wang, Xiaoke ; Li, Wentao ; Yu, Lisheng. In: Pacific-Basin Finance Journal. RePEc:eee:pacfin:v:88:y:2024:i:c:s0927538x24003202.

Full description at Econpapers || Download paper

2025Crowding in or crowding out? Evidence from discontinuity in the assignment of business R&D subsidies. (2025). Srholec, Martin ; Bajgar, Matj. In: Journal of Public Economics. RePEc:eee:pubeco:v:245:y:2025:i:c:s0047272725000556.

Full description at Econpapers || Download paper

2024Stock return volatility and financial distress: Moderating roles of ownership structure, managerial ability, and financial constraints. (2024). Barky, Walid ; van Nguyen, Phuc ; Huong, Giang Thi. In: International Review of Economics & Finance. RePEc:eee:reveco:v:91:y:2024:i:c:p:634-652.

Full description at Econpapers || Download paper

2024Evaluating the impact of OFDI on the growth quality of industrial firms: A dual-perspective analysis from China. (2024). Wang, Ziqi ; Kong, Qunxi ; Cai, Molly ; Peng, Dan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:1616-1627.

Full description at Econpapers || Download paper

2025Strategic emerging industries and innovation: Evidence from China. (2025). Xiang, DI ; Luo, Weijie ; Zhang, Xiaoming. In: International Review of Economics & Finance. RePEc:eee:reveco:v:98:y:2025:i:c:s1059056025000218.

Full description at Econpapers || Download paper

2025Towards an optimal effect of government technology innovation policy mix: the case of government procurement and research and development subsidies with evidence from China. (2025). Appolloni, Andrea ; Yang, Yusen ; Cao, Fuguo ; Guo, Shaobo. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:100:y:2025:i:c:s0038012125000710.

Full description at Econpapers || Download paper

2025The local effects and neighborhood effects of high-speed railway on urban entrepreneurial vitality: Evidence from China. (2025). Wang, Ke-Liang ; Jiang, Nana. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:98:y:2025:i:c:s0038012125000217.

Full description at Econpapers || Download paper

2024Do multinational enterprises’ overseas investment activities promote their green transition performance? Evidence from Chinese listed companies. (2024). Sun, Chuanwang ; Zhang, Wenyue. In: Structural Change and Economic Dynamics. RePEc:eee:streco:v:71:y:2024:i:c:p:594-608.

Full description at Econpapers || Download paper

2024University procurement-led innovation: Sources, procedures, and effects. Some field-study evidence. (2024). Patsali, Sofia. In: Technovation. RePEc:eee:techno:v:130:y:2024:i:c:s0166497223002122.

Full description at Econpapers || Download paper

2024Beyond funding: The moderating role of firms R&D human capital on government support and venture capital for regional innovation in China. (2024). Edeh, Jude ; Prevot, Frederic. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:203:y:2024:i:c:s0040162524001471.

Full description at Econpapers || Download paper

2025Enhancing foresight models with network science: Measuring innovation feedbacks within the Chain-Linked Model. (2025). Osullivan, Eoin ; Evans, Tim S ; Ho, Martin. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:213:y:2025:i:c:s0040162525000411.

Full description at Econpapers || Download paper

2025The impact of international technology spillovers on digital inequality in China. (2025). Yuan, Hang ; Feng, Wei. In: Technology in Society. RePEc:eee:teinso:v:81:y:2025:i:c:s0160791x25000545.

Full description at Econpapers || Download paper

2024Do trade agreements contribute to the decline in labor share? Evidence from Latin American countries. (2024). Ruffo, Hernán ; Gonzalez-Rozada, Martin. In: World Development. RePEc:eee:wdevel:v:177:y:2024:i:c:s0305750x24000317.

Full description at Econpapers || Download paper

2025Opening up military innovation: causal effects of reforms to US defense research. (2025). van Reenen, John ; Howell, Sabrina T ; Wong, Jun ; Rathje, Jason. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:128343.

Full description at Econpapers || Download paper

2025New Technologies and the College Premium. (2025). Kalyani, Aakash ; Restrepo, Pascual ; Hassan, Tarek A. In: Working Papers. RePEc:fip:fedlwp:101744.

Full description at Econpapers || Download paper

2024Public R&D and Growth: A dynamic Panel Vector-Error-Correction Model Analysis for 14 OECD Countries. (2024). Ziesemer, Thomas. In: Economies. RePEc:gam:jecomi:v:12:y:2024:i:8:p:216-:d:1461688.

Full description at Econpapers || Download paper

2024The Impact of Global Value Chain Reconstruction on the Innovative Latitude High-Quality Development of Reverse OFDI in China—From the Perspective of Jiangsu Province. (2024). Zhu, Xiyue ; Huang, Chuanrong. In: Sustainability. RePEc:gam:jsusta:v:16:y:2024:i:16:p:6882-:d:1453889.

Full description at Econpapers || Download paper

2024A Simulation of the Necessary Total Factor Productivity Growth and Its Feasible Dual Circulation Source Pathways to Achieve China’s 2035—Economic Goals: A Dynamic Computational General Equilibrium Study. (2024). Qi, Zike. In: Sustainability. RePEc:gam:jsusta:v:16:y:2024:i:18:p:8237-:d:1482971.

Full description at Econpapers || Download paper

2024Does Quality Certification or Product Diversification Improve the Performance of Small and Medium Enterprises?. (2024). Nguyen, Van-Hoa ; Le, Duc-Niem. In: Sustainability. RePEc:gam:jsusta:v:16:y:2024:i:5:p:2023-:d:1348778.

Full description at Econpapers || Download paper

2025Are less polluting and synergistic farming technologies complementary?. (2025). Blazy, Jean-Marc ; Thomas, Alban ; Fares, Mhand. In: Post-Print. RePEc:hal:journl:hal-05008165.

Full description at Econpapers || Download paper

2024Is a College Education Still Enough? The IT-Labor Relationship with Education Level, Task Routineness, and Artificial Intelligence. (2024). Browning, Tyson R ; Yao, Yuliang ; Peng, Gang ; Zhang, Dawei. In: Information Systems Research. RePEc:inm:orisre:v:35:y:2024:i:3:p:992-1010.

Full description at Econpapers || Download paper

2024The dark side of finance: the link between financialisation and labour investment in emerging Asian countries. (2024). Doruk, Ömer. In: Economic Change and Restructuring. RePEc:kap:ecopln:v:57:y:2024:i:6:d:10.1007_s10644-024-09809-4.

Full description at Econpapers || Download paper

2024Overcoming barriers to technology transfer: empirical evidence from the German Democratic Republic. (2024). Medase, Kehinde ; Jindra, Bjrn ; Hipp, Ann. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:49:y:2024:i:5:d:10.1007_s10961-023-10055-5.

Full description at Econpapers || Download paper

2025Insider Stock Ownership and Earnings Persistence: Evidence from China. (2025). Minsi, Lin ; Razali, Fazlida Mohd ; Johari, Razana Juhaida ; Jasni, Nur Syuhada. In: Public Organization Review. RePEc:kap:porgrv:v:25:y:2025:i:2:d:10.1007_s11115-025-00830-3.

Full description at Econpapers || Download paper

2025Ownership Changes and Firm Dynamics. (2025). Bruggemann, Bettina ; Mahone, Zachary L ; Palmer, Thomas. In: Department of Economics Working Papers. RePEc:mcm:deptwp:2025-03.

Full description at Econpapers || Download paper

2024The Economics of Infertility: Evidence from Reproductive Medicine. (2024). Polyakova, Maria ; Persson, Petra ; Bogl, Sarah ; Moshfegh, Jasmin. In: NBER Working Papers. RePEc:nbr:nberwo:32445.

Full description at Econpapers || Download paper

2024Measuring the macroeconomic responses to public investment in innovation: evidence from OECD countries. (2024). Deleidi, Matteo ; Mazzucato, Mariana ; Ciaffi, Giovanna. In: Industrial and Corporate Change. RePEc:oup:indcch:v:33:y:2024:i:2:p:363-382..

Full description at Econpapers || Download paper

2024Novel enterprises digital transformation influence empirical study. (2024). Sun, Xiaowen ; Wang, Zheng. In: PLOS ONE. RePEc:plo:pone00:0296693.

Full description at Econpapers || Download paper

2024Multifactor productivity growth enhancers across industries and countries: Firm-level evidence. (2024). Nakatani, Ryota. In: MPRA Paper. RePEc:pra:mprapa:120503.

Full description at Econpapers || Download paper

2025Corporate social responsibility, industry competition and firm productive efficiency: evidence from semi-parametric and non-parametric analysis. (2025). Hamza, Taher ; Nizar, Hamza ; Lakhal, Faten. In: Annals of Operations Research. RePEc:spr:annopr:v:347:y:2025:i:1:d:10.1007_s10479-023-05683-x.

Full description at Econpapers || Download paper

2025The National Civilized City campaign and corporate green innovation: evidence from a quasi-natural experiment in China. (2025). Zhou, Zhongsheng ; Xu, Wei ; Liu, Jiawei. In: The Annals of Regional Science. RePEc:spr:anresc:v:74:y:2025:i:1:d:10.1007_s00168-024-01333-7.

Full description at Econpapers || Download paper

2025Diffusion or polarization: the spatial spillover of digitalization on urban innovation. (2025). Du, Zhuoya ; Wang, Qian. In: The Annals of Regional Science. RePEc:spr:anresc:v:74:y:2025:i:2:d:10.1007_s00168-025-01395-1.

Full description at Econpapers || Download paper

2024Foreign capital inflows, exchange rates, and government stability. (2024). McCloud, Nadine ; Delgado, Michael S ; Jin, Man. In: Empirical Economics. RePEc:spr:empeco:v:66:y:2024:i:3:d:10.1007_s00181-023-02490-y.

Full description at Econpapers || Download paper

2024Cross-country convergence: to be or not to be, that is the question. (2024). Lähdemäki, Sakari ; Lahdemaki, Sakari. In: Empirical Economics. RePEc:spr:empeco:v:67:y:2024:i:2:d:10.1007_s00181-024-02561-8.

Full description at Econpapers || Download paper

2024The reverse technology spillover effect of outward foreign direct investment, energy efficiency and carbon emissions. (2024). Liu, Suxia ; Wang, Rong. In: Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development. RePEc:spr:endesu:v:26:y:2024:i:7:d:10.1007_s10668-023-03323-9.

Full description at Econpapers || Download paper

2024Multifactor productivity growth enhancers across industries and countries: firm-level evidence. (2024). Nakatani, Ryota. In: Eurasian Business Review. RePEc:spr:eurasi:v:14:y:2024:i:2:d:10.1007_s40821-024-00265-8.

Full description at Econpapers || Download paper

2024Understanding Labour Productivity Convergence: Empirical Evidence from South Asia. (2024). Mahmood, Tahir ; Ahmad, Sareer ; Ullah, Kifayat. In: The Indian Journal of Labour Economics. RePEc:spr:ijlaec:v:67:y:2024:i:4:d:10.1007_s41027-024-00543-z.

Full description at Econpapers || Download paper

2024Market concentration, promoter ownership and firm performance: evidence from Indian corporate firms. (2024). Roy, Ujjayini ; Chakraborty, Indrani. In: Indian Economic Review. RePEc:spr:inecre:v:59:y:2024:i:1:d:10.1007_s41775-024-00217-z.

Full description at Econpapers || Download paper

2024Determinants of High-tech Exports: New Evidence from OECD Countries. (2024). Navarro Zapata, Amadeo ; Arrazola, Maria ; Hevia, Jose. In: Journal of the Knowledge Economy. RePEc:spr:jknowl:v:15:y:2024:i:1:d:10.1007_s13132-023-01116-z.

Full description at Econpapers || Download paper

2024Measuring the Impact of R&D&I Subsidies on Innovative Inputs and Outputs in Polish Manufacturing Firms. (2024). Tomaszewski, Tomasz ; Yaghi, Adriana Zabocka-Abi. In: Journal of the Knowledge Economy. RePEc:spr:jknowl:v:15:y:2024:i:1:d:10.1007_s13132-023-01194-z.

Full description at Econpapers || Download paper

2024Institutional Similarity and Bilateral FDI. (2024). El-Shagi, Makram ; Muhammad, Bashir. In: Journal of the Knowledge Economy. RePEc:spr:jknowl:v:15:y:2024:i:1:d:10.1007_s13132-023-01312-x.

Full description at Econpapers || Download paper

2025Internationalisation as a boost for many firms: evidence from Germany. (2025). Goldbach, Stefan ; Frey, Rainer. In: Review of World Economics (Weltwirtschaftliches Archiv). RePEc:spr:weltar:v:161:y:2025:i:3:d:10.1007_s10290-024-00567-z.

Full description at Econpapers || Download paper

2025Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002.

Full description at Econpapers || Download paper

2024(Breaking) Intergenerational Transmission of Mental Health. (2024). Karbownik, Krzysztof ; Ginja, Rita ; Bütikofer, Aline ; Landaud, Fanny ; Butikofer, Aline. In: Journal of Human Resources. RePEc:uwp:jhriss:v:59:y:2024:i:s:p:s108-s151.

Full description at Econpapers || Download paper

2024Financial incentives and prescribing behavior in primary care. (2024). Herr, Annika ; Gravelle, Hugh ; Bodnar, Olivia ; Gutacker, Nils. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:696-713.

Full description at Econpapers || Download paper

2025Renewable energy transition and green productivity growth in sub‐Saharan African countries: A convergence analysis. (2025). Diallo, Souleymane. In: Natural Resources Forum. RePEc:wly:natres:v:49:y:2025:i:3:p:2794-2813.

Full description at Econpapers || Download paper

2024Public procurement can hinder innovation. (2024). Krieger, Bastian ; Strecke, Linus ; Pruefer, Malte. In: ZEW Discussion Papers. RePEc:zbw:zewdip:287768.

Full description at Econpapers || Download paper

Works by Frank Lichtenberg:

YearTitleTypeCited
1998The Impact and Organization of Publicly-Funded Research and development in the European Community In: Annals of Economics and Statistics.
[Full Text][Citation analysis]		article27
1997The Impact and Organization of Publicly-Funded Research and Development in the European Community.(1997) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 27		paper
2005Are the More Educated More Likely to Use New Drugs? In: Annals of Economics and Statistics.
[Full Text][Citation analysis]		article41
2010Are the More Educated More Likely to Use New Drugs?.(2010) In: NBER Chapters.
[Citation analysis]
This paper has nother version. Agregated cites: 41		chapter
1984The Relationship between Federal Contract R&D and Company R&D. In: American Economic Review.
[Citation analysis]		article86
1988The Private R&D Investment Response to Federal Design and Technical Competitions. In: American Economic Review.
[Full Text][Citation analysis]		article116
1996Do (More and Better) Drugs Keep People Out of Hospitals? In: American Economic Review.
[Full Text][Citation analysis]		article32
2007The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data In: American Economic Review.
[Full Text][Citation analysis]		article16
1989Errors of Measurement in Output Deflators. In: Journal of Business & Economic Statistics.
[Citation analysis]		article25
1986Errors of Measurement in Output Deflators.(1986) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 25		paper
1987Productivity and Changes in Ownership of Manufactoring Plants In: Brookings Papers on Economic Activity.
[Full Text][Citation analysis]		article95
2017The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia In: The Economic Record.
[Full Text][Citation analysis]		article1
1989THE EFFECT OF CONTROL CHANGES ON THE PRODUCTIVITY OF U.S. MANUFACTURING PLANTS In: Journal of Applied Corporate Finance.
[Full Text][Citation analysis]		article6
1987The Effect of Government Funding on Private Industrial Research and Development: A Re-assessment. In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article69
1989Contributions to Federal Election Campaigns by Government Contractors. In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article2
1988CONTRIBUTIONS TO FEDERAL ELECTION CAMPAIGNS BY GOVERNMENT CONTRACTORS.(1988) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 2		paper
1998Computer Use and Productivity Growth in US Federal Government Agencies, 1987–92 In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article16
2010Pharmaceutical Price Discrimination and Social Welfare In: Capitalism and Society.
[Full Text][Citation analysis]		article4
2008Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article1
2007Pharmaceutical Innovation and US Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data.(2007) In: NBER Chapters.
[Citation analysis]
This paper has nother version. Agregated cites: 1		chapter
2010Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article3
2010Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia.(2010) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2013The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article13
2012The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files.(2012) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 13		paper
2017The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004–2012 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2018The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2019The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis.(2019) In: CESifo Working Paper Series.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2021The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998–2015 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2002The Effects of Medicare on Health Care Utilization and Outcomes In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article34
2002The Effects of Medicare on Health Care Utilization and Outcomes.(2002) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 34		chapter
2018The Impact of New Drug Launches on Longevity Growth in Nine Middle Eastern and African Countries, 2007–2015 In: Review of Middle East Economics and Finance.
[Full Text][Citation analysis]		article0
1989USING LINKED CENSUS R&D-LRD DATA TO ANALYZE THE EFFECT OF R&D INVESTMENT ON TOTAL FACTOR PRODUCTIVITY GROWTH In: Working Papers.
[Full Text][Citation analysis]		paper6
1989The Effect Of Takeovers On The Employment And Wages Of Central-Office And Other Personnel In: Working Papers.
[Full Text][Citation analysis]		paper8
1989THE EFFECT OF TAKEOVERS ON THE EMPLOYMENT AND WAGES OF CENTRAL-OFFICE AND OTHER PERSONNEL.(1989) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 8		paper
1989The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 8		paper
1989The Effects Of Leveraged Buyouts On Productivity And Related Aspects Of Firm Behavior In: Working Papers.
[Full Text][Citation analysis]		paper194
1990The effects of leveraged buyouts on productivity and related aspects of firm behavior.(1990) In: Journal of Financial Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 194		article
1989The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 194		paper
1997The Allocation of Publicly-Funded Biomedical Research In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper16
2001The Allocation of Publicly Funded Biomedical Research.(2001) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 16		chapter
1998The Allocation of Publicly-Funded Biomedical Research.(1998) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 16		paper
2009Response to Baker and Fugh-Bermans Critique of my Paper, Why has Longevity Increased more in some States than in others? In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper1
2010The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper3
2012The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper2
2014The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data.(2014) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		article
2000The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper6
2001The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey.(2001) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2000Sources of U.S. Longevity Increase, 1960 -1997 In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper14
2002Sources of U.S. Longevity Increase, 1960-1997.(2002) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14		paper
2013The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper0
2015The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.(2015) In: Social Science & Medicine.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
2015Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010 In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper0
2015Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010.(2015) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
1999Information technology and its impact on firm-level productivity: evidence from government and private data sources, 1977-1993 In: Canadian Journal of Economics.
[Full Text][Citation analysis]		article58
2018The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries In: JODE - Journal of Demographic Economics.
[Full Text][Citation analysis]		article2
2018THE IMPACT OF NEW DRUG LAUNCHES ON LIFE-YEARS LOST IN 2015 FROM 19 TYPES OF CANCER IN 36 COUNTRIES.(2018) In: Journal of Demographic Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		article
2018The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		paper
2018The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		paper
2010Spurious correlation in estimation of the health production function: A note In: Economics Bulletin.
[Full Text][Citation analysis]		article7
2009Spurious correlation in estimation of the health production function: A note.(2009) In: SOI - Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 7		paper
1999Managerial ownership and firm performance: A re-examination using productivity measurement In: Journal of Corporate Finance.
[Full Text][Citation analysis]		article75
1989IR & D project data and theories of R & D investment In: Journal of Economic Dynamics and Control.
[Full Text][Citation analysis]		article1
1988IR&D Project Data and Theories of R&D Investment.(1988) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
1998International R&D spillovers: A comment In: European Economic Review.
[Full Text][Citation analysis]		article221
1998International R&D spillovers comment.(1998) In: ULB Institutional Repository.
[Citation analysis]
This paper has nother version. Agregated cites: 221		paper
2014The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009 In: Economics & Human Biology.
[Full Text][Citation analysis]		article4
2003The effect of new drug approvals on HIV mortality in the US, 1987-1998 In: Economics & Human Biology.
[Full Text][Citation analysis]		article3
2022The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries In: Economics & Human Biology.
[Full Text][Citation analysis]		article0
1987Changing market opportunities and the structure of R & D investment : The case of energy In: Energy Economics.
[Full Text][Citation analysis]		article2
1995Economics of defense R&D In: Handbook of Defense Economics.
[Full Text][Citation analysis]		chapter20
2014The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010 In: Health Policy.
[Full Text][Citation analysis]		article2
2012Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization In: International Review of Law and Economics.
[Full Text][Citation analysis]		article7
1994Ownership structure and corporate performance in Japan In: Japan and the World Economy.
[Full Text][Citation analysis]		article78
1992Ownership Structure and Corporate Performance in Japan.(1992) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 78		paper
1988The burden of government : , Stanford: Hoover Institution Press, 1986. x + 188 pp., $23.95 In: Journal of Comparative Economics.
[Full Text][Citation analysis]		article0
1992Industrial de-diversification and its consequences for productivity In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article54
1990Industrial De-Diversification and Its Consequences for Productivity.(1990) In: Economics Working Paper Archive.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 54		paper
1990Industrial De-Diversification and its Consequences for Productivity.(1990) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 54		paper
1995Labour market institutions, liquidity constraints, and macroeconomic stability In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article0
1991Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability.(1991) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
1995Rejoinder to comment by Maarten Vendrik In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article0
1989How elastic is the governments demand for weapons? In: Journal of Public Economics.
[Full Text][Citation analysis]		article4
1988HOW ELASTIC IS THE GOVERNMENTS DEMAND FOR WEAPONS?.(1988) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 4		paper
1989How Elastic is the Governments Demand for Weapons?.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		paper
2004Sources of U.S. longevity increase, 1960-2001 In: The Quarterly Review of Economics and Finance.
[Full Text][Citation analysis]		article27
1986Energy prices and induced innovation In: Research Policy.
[Full Text][Citation analysis]		article22
1990Issues in measuring industrial R&D In: Research Policy.
[Full Text][Citation analysis]		article4
2010Pharmaceutical innovation and mortality in the United States, 1960-2000. A commentary on Schnittker and Karandinos In: Social Science & Medicine.
[Full Text][Citation analysis]		article0
2013The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007 In: Social Science & Medicine.
[Full Text][Citation analysis]		article1
2011The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007.(2011) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2022The impact of biomedical innovation on longevity and health In: Chapters.
[Full Text][Citation analysis]		chapter0
2008Pharmaceutical innovation and the longevity of Australians: A first look In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter4
2008Pharmaceutical innovation and the longevity of Australians: a first look.(2008) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		paper
2010The effect of drug vintage on survival: Micro evidence from Puerto Ricos Medicaid program In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter1
2004The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Ricos Medicaid Program.(2004) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2012The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter0
2012The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey.(2012) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2003The benefits to society of new drugs: a survey of the econometric evidence In: Proceedings.
[Full Text][Citation analysis]		article2
1996The European Strategic Program for Research in Information Technologie (ESPRIT): An Ex-Post Analysis. In: Columbia - Graduate School of Business.
[Citation analysis]		paper3
1996Computer Use and Productivity Growth in federal Government Agencies. In: Columbia - Graduate School of Business.
[Citation analysis]		paper4
1996The Effect of New Political Administration on Federal Government Productivity and Employment. In: Columbia - Graduate School of Business.
[Citation analysis]		paper1
1996The Effect of New Political Administration on Federal Government Productivity and Employment.(1996) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
1988GOVERNMENT SUBSIDIES TO PRIVATE MILITARY R&D INVESTMEN: DODS IR&D POLICY. In: Columbia - Graduate School of Business.
[Citation analysis]		paper5
1988Government Subsidies to Private Military R&D Investment: DODs IR&D Policy.(1988) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 5		paper
1988CROWDING OUT: THE IMPACT OF THE STRATEGIC DEFENSE INITIATIVE ON U.S. CIVILIAN R&D INVESTMENT AND INDUSTRIAL COMPETITIVENESS In: Columbia - Graduate School of Business.
[Citation analysis]		paper0
2020Are patients more adherent to newer drugs? In: Health Care Management Science.
[Full Text][Citation analysis]		article2
2011The quality of medical care, behavioral risk factors, and longevity growth In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article11
2009The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth.(2009) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 11		paper
2015The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011 In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article5
2015The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011.(2015) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 5		paper
2024Has pharmaceutical innovation reduced the average cost of U.S. health care episodes? In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article0
2005The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article34
2003The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 34		paper
1996Book Reviews In: Journal of Economics.
[Full Text][Citation analysis]		article0
1991The Managerial Response to Regulation of Financial Reporting for Segments of a Business Enterprise. In: Journal of Regulatory Economics.
[Citation analysis]		article14
1989The Effects of Mergers on Prices, Costs, And Capacity Utilization in the U.S. Air Transportation Industry, 1970-84 In: Economics Working Paper Archive.
[Full Text][Citation analysis]		paper1
1989The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2000The Impact of Hospital Quality-Related Practices on Health Outcomes In: Center for Policy Research Working Papers.
[Full Text][Citation analysis]		paper0
1984R&D and Productivity Growth at the Industry Level: Is There Still a Relationship? In: NBER Chapters.
[Full Text][Citation analysis]		chapter126
2005Pharmaceutical Knowledge-Capital Accumulation and Longevity In: NBER Chapters.
[Full Text][Citation analysis]		chapter3
2016The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis In: NBER Chapters.
[Full Text][Citation analysis]		chapter0
2018The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger In: NBER Chapters.
[Full Text][Citation analysis]		chapter0
1981Training, Tenure, and Productivity In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
1982R and D and Productivity at the Industry Level: Is There Still a Relationship? In: NBER Working Papers.
[Full Text][Citation analysis]		paper11
2004The Expanding Pharmaceutical Arsenal in the War on Cancer In: NBER Working Papers.
[Full Text][Citation analysis]		paper11
2004The expanding pharmaceutical arsenal in the war on cancer.(2004) In: 2004 Meeting Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 11		paper
2006The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
2006The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper5
2006Importation and Innovation In: NBER Working Papers.
[Full Text][Citation analysis]		paper8
2007IMPORTATION AND INNOVATION.(2007) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 8		article
2008Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003 In: NBER Working Papers.
[Full Text][Citation analysis]		paper4
2009Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country‐level data on 20 OECD countries, 1995–2003.(2009) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		article
2010Has medical innovation reduced cancer mortality? In: NBER Working Papers.
[Full Text][Citation analysis]		paper13
2014Has Medical Innovation Reduced Cancer Mortality?.(2014) In: CESifo Economic Studies.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 13		article
1985The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence In: NBER Working Papers.
[Full Text][Citation analysis]		paper6
2012Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009 In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2013The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
1986Private Investment in R&D to Signal Ability to Perform Government Contracts In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
2015Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients In: NBER Working Papers.
[Full Text][Citation analysis]		paper0
2017The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013 In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2018The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality In: NBER Working Papers.
[Full Text][Citation analysis]		paper4
2019The long-run impact of new medical ideas on cancer survival and mortality.(2019) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		article
2019How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
1988Technical Change, Learning, and Wages In: NBER Working Papers.
[Full Text][Citation analysis]		paper6
1989The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper180
1991The Impact of R&D Investment on Productivity--New Evidence Using Linked R&D-LRD Data..(1991) In: Economic Inquiry.
[Citation analysis]
This paper has nother version. Agregated cites: 180		article
2022The Effects of Off-label Drug Use on Disability and Medical Expenditure In: NBER Working Papers.
[Full Text][Citation analysis]		paper0
2022The effects of off-label drug use on disability and medical expenditure.(2022) In: Ruhr Economic Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
1992R&D Investment and International Productivity Differences In: NBER Working Papers.
[Full Text][Citation analysis]		paper125
1993The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis In: NBER Working Papers.
[Full Text][Citation analysis]		paper54
1996The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality In: NBER Working Papers.
[Full Text][Citation analysis]		paper10
1996Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992 In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
1996International R&D Spillovers: A Re-Examination In: NBER Working Papers.
[Full Text][Citation analysis]		paper60
1998Pharmaceutical Innovation, Mortality Reduction, and Economic Growth In: NBER Working Papers.
[Full Text][Citation analysis]		paper24
2001The Effect of New Drugs on Mortality from Rare Diseases and HIV In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
2002Benefits and Costs of Newer Drugs: An Update In: NBER Working Papers.
[Full Text][Citation analysis]		paper15
2007Benefits and costs of newer drugs: an update.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 15		article
2002The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2002The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs In: NBER Working Papers.
[Full Text][Citation analysis]		paper38
2002The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry In: NBER Working Papers.
[Full Text][Citation analysis]		paper33
2002The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry.(2002) In: Journal of Law and Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 33		article
2002The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in The US Pharmaceuticals Industry.(2002) In: Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 33		paper
2002Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as equipment for your health In: NBER Working Papers.
[Full Text][Citation analysis]		paper14
2007Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as Equipment for Your Health.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14		article
2003Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act In: NBER Working Papers.
[Full Text][Citation analysis]		paper25
2002Using Patents Data to Map Technical Change in Health-Related Areas In: OECD Science, Technology and Industry Working Papers.
[Full Text][Citation analysis]		paper2
2020The Health Impact of, and access to, New Drugs in Korea In: East Asian Economic Review.
[Full Text][Citation analysis]		article0
2018The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the United States, 1999-2013 In: The American Economist.
[Full Text][Citation analysis]		article0
2006Has Using Newer Drugs Reduced Admissions to Hospitals and Nursing Homes? In: Swiss Journal of Economics and Statistics (SJES).
[Full Text][Citation analysis]		article0
2010Impact of Specialization on Health Outcomes – Evidence from U.S. Cancer Data In: SOI - Working Papers.
[Full Text][Citation analysis]		paper0
2015The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010 In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article2
2013The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007 In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2022The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017 In: Journal of Evolutionary Economics.
[Full Text][Citation analysis]		article0
2017The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013 In: Latin American Economic Review.
[Full Text][Citation analysis]		article0
2006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003 In: PharmacoEconomics.
[Full Text][Citation analysis]		article9
2012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7 In: PharmacoEconomics.
[Full Text][Citation analysis]		article5
2022The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019 In: Swiss Journal of Economics and Statistics.
[Full Text][Citation analysis]		article0
2009The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004 In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]		article5
2024The impact of biomedical innovation on the disability of elderly Medicare recipients, 2013–2019 In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]		article0
2011Has Pharmaceutical Innovation Reduced Social Security Disability Growth? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]		article0
1984Interindustry Technology Flows and Productivity Growth: A Re-examination. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article124
1987The Comparative Advantage of Educated Workers in Implementing New Technology. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article492
1988Estimation of the Internal Adjustment Costs Model Using Longitudinal Establishment Data. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article20
1994Testing the Convergence Hypothesis. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article91
2001Does Foreign Direct Investment Transfer Technology Across Borders? In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article354
2001Does foreign direct investment transfer technology across borders?.(2001) In: ULB Institutional Repository.
[Citation analysis]
This paper has nother version. Agregated cites: 354		paper
2014The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010 In: Journal of Human Capital.
[Full Text][Citation analysis]		article1
1990The Effect of Ownership Changes on the Employment and Wages of Central Office and Other Personnel. In: Journal of Law and Economics.
[Full Text][Citation analysis]		article49
2021Are drug prices subject to creative destruction? Evidence from the US, 1997–2017 In: Health Economics.
[Full Text][Citation analysis]		article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 20 2025. Contact: CitEc Team